Controlled interactions between macromolecules are fundamental regulatory layers. Hijacking these circuits via proximity-inducing small molecules offers many therapeutic opportunities. The organizers, Georg Winter and Cristina Mayor-Ruiz, report on the latest trends in this emerging field discussed at the 39th IRB-BioMed Conference in Barcelona.
References
Kofink, C. et al. Nat. Commun. 13, 5969 (2022).
Tsai, J. M. et al. Mol. Cell 83, 2753–2767 e10 (2023).
Hsia, O. et al. Preprint at bioRxiv https://doi.org/10.1101/2023.02.14.528511 (2023).
Ahn, G. et al. Science 382, eadf6249 (2023).
Hoi, D. M. et al. Cell 186, 2176–2192 e22 (2023).
Morreale, F. E. et al. Cell 185, 2338–2353 e18 (2022).
Raina, K. et al. Preprint at bioRxiv https://doi.org/10.1101/2023.01.01.522436 (2023).
Tong, Y. et al. Nature 618, 169–179 (2023).
Szulc, N. A. et al. Preprint at bioRxiv https://doi.org/10.1101/2022.05.19.492622 (2022).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Competing interests
G.E.W. is a scientific founder and shareholder of Proxygen and Solgate. His lab has received research funding from Pfizer. C.M.-R. is part of the scientific advisory board of Nostrum Biodiscovery. Her lab has received or receives sponsored research support from Almirall and Aelin Tx.
Rights and permissions
About this article
Cite this article
Winter, G.E., Mayor-Ruiz, C. Proximity-inducing pharmacology. Nat Chem Biol 20, 13–14 (2024). https://doi.org/10.1038/s41589-023-01492-2
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41589-023-01492-2
- Springer Nature America, Inc.